Press Releases


Latest News


Adamas Announces Data Update at the 68th American Academy of Neurology Annual Meeting
Apr 14, 2016 | General Releases

Adamas Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 23, 2016 | Financial Releases

Adamas Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
Feb 22, 2016 | General Releases

Adamas Pharmaceuticals Provides Review of 2015 and Projected Future Milestones
Jan 12, 2016 | General Releases

Adamas Announces Pricing of Public Offering of Common Stock
Jan 7, 2016 | General Releases

Adamas Announces Proposed Public Offering of Common Stock
Jan 5, 2016 | General Releases

Adamas Announces Positive Top-Line Phase 3 Results of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson's Disease
Dec 23, 2015 | General Releases

Adamas to Host Conference Call and Webcast to Provide Company Update
Dec 22, 2015 | General Releases

Adamas Completes Enrollment of Its Phase 3 EASE LID 3 Study Evaluating ADS-5102 for Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
Dec 14, 2015 | General Releases

Adamas Pharmaceuticals to Present at the 27th Annual Piper Jaffray Healthcare Conference
Nov 17, 2015 | General Releases

Pages:  1 2 3 4 5 6 7 8 9 10